Monogram Health pays $2.4M to settle Medicare Advantage upcoding allegations
Monogram Health, a kidney disease care provider, will pay $2.4 million to settle allegations that it submitted inaccurate risk-adjustment data to Medicare Advantage plans from 2019 through 2022. The Department of Justice investigation focused on upcoding, specifically the submission of diagnosis codes that were not supported by patient medical records. This settlement is part of a broader, multi-year enforcement push by federal agencies against risk-adjustment fraud in the MA program. The settlement requires Monogram to adhere to a five-year Corporate Integrity Agreement with HHS-OIG. Risk adjustment documentation for MA patients is now under intense scrutiny. Practices with MA contracts should review their own documentation and coding audit protocols for hierarchical condition categories (HCCs) immediately.